Samsung Medical Center is a tertiary hospital located in Irwon-Dong of Gangnam-Gu, Seoul, South Korea. SMC is composed of Samsung Seoul Hospital, Kangbook Samsung Hospital, Samsung Changwon Hospital, and Samsung Life Sciences Research Center. SMC was founded on November 9, 1994.

During the past decade, Samsung Changwon Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Samsung Changwon Hospital" #1 collaborator was "Canadian Cancer Trials Group" with 1 trials as a collaborator, "NRG Oncology" with 1 trials as a collaborator and "National Cancer Institute (NCI)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Samsung Changwon Hospital" are "Endometrial Clear Cell Adenocarcinoma" (1 trials), "Endometrial Dedifferentiated Carcinoma" (1 trials), "Endometrial Endometrioid Adenocarcinoma" (1 trials), "Endometrial Mixed Cell Adenocarcinoma" (1 trials) and "Endometrial Serous Adenocarcinoma" (1 trials). Many other conditions were trialed in "Samsung Changwon Hospital" in a lesser frequency.

Most popular intervention types in "Samsung Changwon Hospital" are "Drug" (2 trials), "Biological" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (2 trials), "Paclitaxel" (2 trials), "Computed Tomography" (1 trials), "Letrozole" (1 trials) and "Pembrolizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Samsung Changwon Hospital" are 2 trials for "Female" genders.

Currently, there are NaN active trials in "Samsung Changwon Hospital". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Samsung Changwon Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Samsung Changwon Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".